Bio-Techne: Judith Klimovsky

Bio-Techne has appointed Judith Klimovsky as an independent director of its board, effective April 24. She will serve on the company's science and technology committee. Bio-Techne's board is now temporarily comprised of 11 directors, including 10 independent ones. Klimovsky is currently the executive VP and chief development officer at Genmab. Before that, she held several senior global clinical and research positions at Novartis Oncology including senior VP and global head of oncology clinical development. She was also regional medical director of Latin America at Merck and held several R&D positions at Bristol-Myers Squibb.